bio-europe® 2016- value and the pricing of innovation
Published 8 years ago • 170 plays • Length 1:08:53Download video MP4
Download video MP3
Similar videos
-
4:39
bio-europe® 2016: j&j's richard mason: 'biomedical innovation can come from anywhere'
-
8:32
bio-europe® 2016: dimerix ceo explains company's different drug combo r&d strategy
-
6:35
bio-europe® 2016: karus ceo highlights niche indications for oncology innovation
-
1:02:31
bio-europe® 2016: the new frontier: aging and health
-
10:27
bio-europe® 2016: biontech's sean marett explains genentech deal rationale
-
9:24
bio-europe spring® 2017: imanova trims phase i and iia trial timelines and costs
-
10:21
bio-europe spring® 2016: how to get takeda ventures to notice your startup
-
1:19:33
the future of biotech: the role of legislation within investment for innovation
-
1:30:16
business of biotech: trends in life science funding & exits
-
12:32
bridge biotherapeutics @ bio international convention 2023
-
12:46
bio-europe spring® 2016: az bioventure hub ceo says aim is an innovative ecosystem
-
7:07
bio-europe spring® 2016: selexis ceo talks licensing, academic partnerships and biosimilars
-
11:28
bio-europe spring® 2016: where can adocia fit in the diabetes market?
-
0:31
bio-europe spring 2023
-
1:04:18
bio-europe® 2016: immunotherapies: partnership models driving cures
-
4:59
bio-europe spring® 2016: lucentis biosimilar to be sold to emerging markets by xbrane biopharma
-
9:58
bio-europe spring® 2016: pila pharma ceo explains potential of "chili receptor" as diabetes therapy
-
59:47
biotech showcase 2018: what it means to be in the era of cures
-
8:16
bio-europe spring® 2014: dealmaking strategies around orphan diseases
-
0:42
bio europe spring digital 2021
-
5:30
bio-europe spring® 2016: ose pharma, effimune mergiong to create european immunotherapy company